Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells. - Fiskus, W; Sharma, S; Shah, B; Portier, B P; Devaraj, S G T; Liu, K; Iyer, S P; Bearss, D; Bhalla, K N (Leukemia (08876924), 2014)